Life Science WORKING COMMITTEE
In Sweden, health is a strategic and prioritized area, aligned with the government’s agenda. Life science more specifically, is becoming increasingly important and Sweden has a strong global track record from a performance perspective.
It is the aim of the American life science affiliates to contribute to Swedish healthcare by effectively providing solutions to improve patient outcomes, delivering scientific and societal value.
It’s our belief that continuous research and development drives treatment innovation, care provision and technology solutions that should be easily accessible to Swedish citizens as this is paramount to high quality healthcare.
We aim to contribute to Swedish healthcare by effectively providing solutions to improve patient outcomes while delivering scientific and societal value.
To achieve this, we need to position Sweden as the global innovation hub for life science and health technology, where all healthcare stakeholders, including patient organizations, academia, healthcare providers, and industry, constructively collaborate.
Healthcare data are sometimes kept in isolated registries and databases making access a long, complex and imperfect process. Sweden has a unique opportunity to follow a patient’s disease journey through different care providers learning, for example, what medical treatments are most effective and for whom.
This animation is supported by the AmCham Life Science Working Committee representing 12 American life science companies that want to keep - and increase - our research and investments within Life Science in Sweden.